|Day Low/High||63.26 / 64.14|
|52 Wk Low/High||54.50 / 78.77|
Levi & Korsinsky announces it has commenced an investigation of DaVita Inc.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of DaVita Inc.
DaVita Strongly Emphasizes Hiring and Retaining Military Veterans
'Rocket Stocks' is our list of companies with short-term gain catalysts and longer-term growth potential.
These stocks are showing off short-term gain catalysts and longer-term growth potential.
Teammates Deliver Clinical Excellence, Improved Patient Care, Innovation, Robust Partnerships, International Growth, Community Leadership
This kidney care provider hasn't lived up to high expectations, but the stock could be a value play in an overbought market.
HealthCare Partners, a DaVita Medical Group, teams up with prominent health care organization in Nevada to continue driving compassionate care and high-quality clinical outcomes
DaVita Teammates Make a Difference this Holiday Season
Bipartisan legislation signed by President Obama will grant access to Medicare Advantage plans
To offer patient-centered care for Medicare beneficiaries, JSA Medical Group, a DaVita Medical Group (NYSE: DVA), and Humana Inc.
Diabetes is the leading cause of kidney disease in United States
DaVita (DVA) today announced it will suspend support for applications to the American Kidney Fund by Medicaid patients who are seeking additional coverage under the Affordable Care Act.